Xin Peng

Xin Peng is a Director of Business Development, Licensing, and Strategy, currently serving as the Associate Director of Biopharma Academic Partnerships at AstraZeneca since 2021. Previously, they held roles such as Senior Technology Transfer Associate at The Henry M. Jackson Foundation for the Advancement of Military Medicine from 2019 to 2021, and ORISE Fellow at the National Institute of Allergy and Infectious Diseases from 2016 to 2018, where they specialized in technology transfer and patent-related transactions. Xin earned a Ph.D. in Chemistry with a focus on medicinal and analytical chemistry from Washington University in St. Louis, where they also completed a postdoctoral research position in 2013-2014. Their diverse academic and professional background spans multiple prestigious institutions, showcasing expertise in technology evaluation, market analysis, and IP strategy.